Between 1954 and 1973. more than 2.000 men entering military service as conscientious objectors participated in Project Whitecoat as medical research volunteers for the Army's biological warfare defense program. An assessment of self-reported, current health status among 358 "exposed" individuals and 164 unexposed control subjects found no conclusive evidence that receipt of investigational agents was related to adverse health outcomes. No differences in current overall health, current exercise levels, self-reported symptoms, and self-reported medical conditions were seen hetween the study groups. Possible associations were seen between exposure to antibiotics or other biological agents and self-reported asthma (13.0% vs. 2.4%, relative risk [RR| = 6.00, 95% confidence interval [Cl] -1.03-34.90, p = 0.050). as well as between receipt of tularemia vaccine(s) and self-reported asthma (13.3% vs. 2.4%. RR -6.15. 95% Cl = 1.03-36.70, p -0.049} and increased frequency/severity of headaches (35.6% vs. 18.3%, RR -2.46, 95% Cl -0.99-6.15. p = 0.074). However, the size of the population under study was insufficient to assert with confidence that these statistical associations are real.
ical Warfare Service assume responsibility. The initial site selected for the program was Edgewood Arsenal, near Aberdeen. Maryland. In 1943. a small National Guard airfield (Detrick Field) just outside Frederick. Maryland, was purchased by the War Department, and the hub ofthe operation was moved to the renamed Camp Detrtck.
The Office of the Army Surgeon General was involved in the biological warfare research and development program from the time of its inception in 1941. hut it was not directly responsible for any activities until 1956. when the U.S. Army Medical Unit at Camp Detrick was activated with a mission to evaluate the threat of biological warfare and to develop approprtate countermeasures.-' During the same year. Camp Detrick became Fort Detrick. From that time to the present. Fort Detrtck has been the home of the nation's biological warfare defense program. The Army Medical Unit was redesignated the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) in 1969. The contrtbutions of USAMRIID and its predecessor to military medical research and national securtty are legion, and the planned integration of USAMRIID with National Institutes of Health and Department of Homeland Securtty programs through the formation of a national biodefense campus at Fort Detrtck"' ensures its future leadership role in this area.
Project Whitecoat was the title given to an Army research program "to use human volunteers in medical studies to evaluate the effect of certain biological pathogens upon humans in an effort to detemiine the vailnerahility to attack with biological agents" (W.S. Augerson, 1976, cited in Ref. 4. p 20) . The objectives of the studies involved were to develop medical defenses against biological warfare and included techniques for rapid diagnosis, improved therapeutic and prophylactic agents, and development of vaccines against biological weapons and endemic disease threats. The program evolved after a sertes of meetings in 1954-1955 hetween representatives of the Army Surgeon General and the Seventh Day Adventist Church. With the background of the Church s philosophy and practice of medical service and encouragement of noncombatancy and its longstanding cooperation with the military in health and medical practice. Project Whitecoat became an accepted and respected \'ehicle by which conscientious objectors could serve the nation."' From its inception in 1954 to its termination in 1973, approximately 2.300 individuals participated in this program, more than 90% of whom were Seventh Day Adventists. Tbe group participated in more than 135 clinical research studies involving exposure to live agents, receipt of investigational vaccines, and studies of metabolic and psychologicaJ effects of environmental-and infection-induced stress.-"^ Most volunteers participated in at least one project, whereas some participated in several. The current study was designed to assess the long-terai effects on the health of these men resulting from their involvement in this vital program.
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Methods
Study Design
This was a controlled, unblinded, retrospective, cohort study to assess the health status of indi\'iduals who volunteered to participate in Project Whitecoat at Fort Detrtck, Maryland, during 1955-1973.
Study Population
Approximately 2.300 men who entered military service and were classified as conscientious objectors participated in Project Whitecoat. Most were assigned to Fort Detrick. Maryland, and individuals there were assigned a vartety of duties in support of the medical research efforts at the facility. Some worked as technicians in research laboratories, some worked as hospital corpsmen. and others were assigned predominantly administrative duties and responsibilities, Pertodically. the group membership was approached regarding interest in participating as volunteers for clinical research studies. Most studies were related to exposure to infectious diseases, for which volunteers would receive proven therapies and occasionally investigational prophylactic agents (e.g., vaccines).
Subjects for this study were recniited from among the membership of the Project Whitecoat alumni group. A total of 358 men who were exposed to an infectious agent or vaccine (study group) and 164 men who participated in research studies as unexposed eontrol subjects (control group) agreed, after signing a wrttten infoniied consent agreement, to complete a self-administered questionnaire that inquired about health status, ongoing clinical symptoms and signs, reproductive outcomes, and diseases or conditions diagnosed by competent medical authorities. The study was renewed and approved by the institutional review board at USAMRIID. as well as by the Human Subjects Research Review Board ofthe U.S, Army Surgeon General.
Exposure Histories
Records for participation in clinical protocols, including receipt of vaccines and disease-causing agents, were obtained by reviewing archives at USAMRIID, The name and type of study in which each volunteer participated were extracted from th'ese records and entered into an automated database for analysis. A total of 197 volunteers received investigational vaccines. The available data did not allow distinction between live vaccines and killed/toxoid products, nor did they allow enumeration of the numbers of different vaccine candidates involved in testing. Two hundred eleven indi\iduals were exposed to disease-causing agents (some of which might have involved exposure to different strains of a given pathogen), and 46 received antibiotics or other therapeutic agents (in physiological or other studies separate from treatment for exposures in other protocols),
Statistical Analyses
The x^ and Fisher exact tests were used to compcire proportions and the ( test was used to compare mean differences between the exposed (study) and control groups. Rate differences between groups were compared with Fisher exact tests adjusted for multiple compartsons using a resampling bootstrap approach (SAS MULTTEST) for sets of related vartahles (e.g., symptoms, diseases and conditions, and reproductive outcomes). To examine the effect of multiple exposures in the exposed (study) group by itself, logistic regression analysis of the number of studies in which subjects were enrolled was used. To examine the possibility that confounder vartables could explain group differences, further analysis was done using logistic regression analysis of demographic vartables. Subgroup analysis was conducted based on class of exposure (vaccine, pathogen, or therapeutic agent). Effects of individual agents were assessed; however, sample sizes were insufficient for conclusive results, All analyses used SAS version 8.2 (SAS Institute. Cary. North Carolina),
The statistical power of this study to detect rate differences between groups was assessed using a power analysis program.Ŵ ith the sample sizes of 358 control subjects and 164 study subjects, with testing at the 5% level of significance (one-tailedj. a minimal difference in relative rtsk (RR) of twofold could be detected with at least 80% probability' for rates of health related outcomes, over a range of background health condiUon rates for the control subjects.
Results
Study Population Charactertstics
Study subjects were male and predominantly (91,0%) Caucasian, The median duration of assignment at Fort Detrtck was 2.0 years (range. 0-8 years). The mean age of the population at the time that the survey was performed was 58.4 years (range. 46-79 years); the majority of study subjects were highly educated (58.2% possessed college or graduate degrees). Although 12.8% of those completing surveys were retired at the time ofthe study, less than one-half (47.9%) were fully employed. No demographic differences were found between subjects who had been exposed to test agents-in the course of participation in clinical research studies and those who had served as control subjects for the same studies (Table I) .
Eighty-seven percent ofthe study participants reported their current state of health as good or excellent, and 72.6% claimed to engage in at least some exercise every week. Exposed and control subjects did not differ with regard to current overall health status or current exercise level (Table II) , A relatively small proportion of individuals reported tobacco and/or alcohol use. Only 14.9% of survey respondents admitted to having ever smoked cigarettes. 7,7% to having ever smoked cigars. 7,9% to having ever smoked a pipe, and 1,1% to having ever used chewing tobacco or snuff. Aside from a slightly higher percentage of subjects who had been exposed to test agents claiming to have quit smoking cigarettes, no differences between the exposed and control groups with regard to tobacco and alcohol consumption were evident (Table II) .
Exposures
Among the 358 exposed subjects. 303 participated in one study while assigned to Fort Detrtck, 75 participated in two studies, 17 participated in three studies, and 1 participated in four studies. Subjects who volunteered to participate in virulent bactertal agent exposure studies (e.g.. Q fever or tularemia) also received curative antibiotics during, or at the conclusion of, each project.
Outcomes
Most (87%) study participants reported having had children. The proportions of exposed and control subjects with children were similar (87.4% and 86.0%. respectively). A total of 1,052 children were reported to have been sired hy the 522 study participants. The vast majority (92,3%) of these children were reported as normal and healthy. No differences between exposed and control groups in the numbers of children per individual. children uith congenital abnormalities, or children with mental retardation were seen (Table 111) ,
No differences between exposed subjects and control subjects were seen with regard to self-reported clinical signs and symptoms or diseases (or other medical conditions) (Tables IV and V] , When symptoms and diseases among individuals who had received all vaccines and those who had received all virulent agents were examined separately, there remained no differences between the groups. Asthma was reported more freqtiently among the group of subjects exposed to all antibiotics or other nonagents than among control subjects (13.0% vs, 2.4%, RR = 6.00.95% confidence interval [CI] -1.03-34.9, p = 0.050, after adjustment for multiple compartsons).
Attempts to assess frequencies of clinical signs and symptoms or diseases by individual vaccine, individual virulent agent, and individual antibiotic/other agent exposure yielded numbers too small for meaningful analysis for all except recipients of Venezuelan equine encephalitis vaccine(s), tularemia vaccine(s). or virulent C. btimdit. Among these exposures, a possible association between asthma and receipt of tularemia vaceine(s) was observed (13,3%ofvaccineesvs. 2.4% of control subjects. RR -6.15, 95% Cl = 1,03-36.70. p = 0.049. after adjustment for multiple compartsons). In the same cohort, an association with an increased frequency of headaches (never or rarely a problem vs. occasionally or more frequently a problem) among tularemia vaccinees was suggested (35.6% vs. 18.3%), but the difference from control subjects did not reach statistical significance (RR = 2.46, 95% CI = 0.99-6.15. p = 0.074, after adjustment for multiple compartsons). There were no differences in any outcome vartables (general health, exercise levels, reproductive outcomes, reported symptoms, or reported medical conditions) between subjects participating in one study and those participating in two or more studies (data not shown). Unit/USAMRIID, such as laboratory technician, animal caretaker, medic, or supply clerk. All duties were noncombatant in nature. All remained full-time soldiers, and most remained at Fort Detrick for the duration of their service obligations. No special consideration or prt\ileges were accorded Project Whitecoat participants.
When volunteers were needed for specific research studies, a brtefmg to an assembly of Project Whitecoat personnel was provided by the commanding officer, regarding the nature and purpose ofthe project, the rtsks involved, and the requirements for each participant. Questions were then entertained. Those expressing interest in participating were subsequently interviewed individually: details of the study were recounted, individuals were allowed to ask questions, and. if the indi\1dual again expressed interest in participating, signed consent was obtained (USAMRIID 1969 Fact Sheet, cited in Ref, 8) .
Durtng the course of the program. Project Whitecoat volunteers participated in approximately 150 studies." Although some of the projects remain classified, the vast majority ofthe work was conducted openly and was reported in the scientific and medical literature. No fatalities directly attrtbutable to participation in these clinical trtals occurred. Although the trtals met and often exceeded the ethical standards of the day for research involving human subjects, the current clinical research climate would preclude repetition of many of these studies today. The data obtained from research invohing Project Whitecoat volunteers therefore stand as unique and represent the only human data available in many areas.
To date, there has been no systematic attempt to assess the long-term impact of these exposures on the health of Project Whitecoat volunteers. In 1991-1992, a questionnaire designed to capture reflections on their expertences, the reasons behind their interest in participating in the program, and demographic profiles was completed by approximately 200 former participants.^ One question in this survey addressed potential residual effeets of program participation on health. At that time, only one indiNidual in the program had been awarded a service-connected disability designation. A "few" other Project Whitecoat participants cited program participation as a cause of current medical problems: none was confirmed by medical review,^" The current study was an attempt to objectively assess the impact of participation in clinical research studies by the Project Whiteeoat population by compartng questionnaire responses from those who were exposed to agents, biologicals, or other potential stressors and those in the program who served as control subjects for the expertments.
Analyses of questionnaires completed by volunteers for this study provided no evidence that exposures sustained by participants in Project Whitecoat were associated with adverse health outcomes. The exposed and control groups were comparable in most demographic and liiestyle parameters. No differences were reported in overall health status between the two groups, and there were no evident effects on reproductive outcomes. Asthma was reported more frequently among subjects exposed to antibiotics or other inert substances than among control subjects, and similar borderline higher frequencies were observed for reported asthma and headaches among subjects exposed to tularemia vaccines. However, the size of the population under study proved insitlficient to conclude that these statistical associations were real.
This study has a number of shortcomings. Mortality rates could not be assessed because ol" incomplete reporting for the total Project Whitecoat population. There are selection and other biases inherent in a volunteer study of this nature, which might have affected our findings. The sample sizes available were insufficient to detect rare health effects. Furthermore, no laboratory studies were performed as part of the study, and no review of medical records was attempted. Tlierefore, health consequences from exposures expertenced by Project Whitecoat participants ntight have been missed. However, the dearth of evidence suggesting adverse health effects reported by the volunteers who agreed to participate argues against such a possibility.
Project Whitecoat represents an important chapter in the history of medical defense against biological weapons and in human expertmentation. The men who volunteered to participate in the seminal studies that pro\1ded proof of concept in so many crttical areas should be heralded for their contrtbutions to science and medicine in both the military and civilian sectors. It is gratifying that no adverse impact on the overall health of Project Whitecoat volunteers could be conclusively attributed to their participation in these important research studies.
